Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sydnexis
AddedFeb 17, 2024
UpdatedJun 18, 2026
Sydnexis

Sydnexis

Series B

Sydnexis: Innovating proprietary treatments for pediatric progressive myopia.

HQ
Del Mar, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Sydnexis, a pioneering company in pediatric ophthalmology, focuses on developing innovative treatments for progressive myopia in children. The company's core mission is to decrease the progression of myopia through a novel, stable, and comfortable topical eyedrop that is administered once daily at bedtime. Sydnexis aims to improve the quality of life for children affected by myopia by providing an effective and easy-to-use treatment option. Their market focus is primarily on pediatric patients who are experiencing progressive myopia.

Key figures affiliated with Sydnexis include leading experts in pediatric ophthalmology and experienced pharmaceutical developers. The company has conducted significant research, including the STAR Study, to validate the efficacy of their treatment. Sydnexis's notable achievements include the development of a proprietary eyedrop formulation that has shown promising results in clinical trials. The overall impact of Sydnexis lies in its potential to revolutionize the treatment of pediatric myopia, offering hope to millions of children worldwide who suffer from this condition.

Sydnexis - Similar Companies

Visus Therapeutics logo

Visus Therapeutics

visustx.com

Nexis Vision logo

Nexis Vision

OcuTerra Therapeutics logo

OcuTerra Therapeutics

ocuterratx.com

Treehouse Eyes logo

Treehouse Eyes

treehouseeyes.com

Surface Ophthalmics logo

Surface Ophthalmics

Visiox logo

Visiox

visioxpharma.com

Hyperion DeFi logo

Hyperion DeFi

eyenovia.com

EyeCyte logo

EyeCyte

eyecyte.com

Ocular Science logo

Ocular Science

ocularscience.com

Scynexis logo

Scynexis

scynexis.com

TherOptix logo

TherOptix

Myra Vision logo

Myra Vision

myravision.com

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

MediPrint Ophthalmics logo

MediPrint Ophthalmics

Synergeyes logo

Synergeyes

synergeyes.com

Sydnexis - Quick Facts

Who are Sydnexis' competitors?

Companies similar to Sydnexis include Visus Therapeutics, Nexis Vision, OcuTerra Therapeutics and Treehouse Eyes.

When was Sydnexis founded?

Sydnexis was founded in 2014.

Where is Sydnexis' headquarters located?

Sydnexis' headquarters is located in Del Mar, CA, US.

When was Sydnexis' last funding round?

Sydnexis' most recent funding round was for $45M (USD) in August 2021.

How much has Sydnexis raised to-date?

As of Aug 10, 2021, Sydnexis has raised a total of $50.5M (USD).

How many employees does Sydnexis have?

Sydnexis has 33 employees as of Feb 5, 2024.

Sydnexis - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Eye Drops
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research